Business Description
BrightPath Biotherapeutics Co Ltd
ISIN : JP3274140007
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.59 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.65 | |||||
Debt-to-EBITDA | -0.41 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.53 | |||||
Beneish M-Score | -4.32 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -30.8 | |||||
3-Year EBITDA Growth Rate | 16.3 | |||||
3-Year EPS without NRI Growth Rate | 17 | |||||
3-Year FCF Growth Rate | 23.5 | |||||
3-Year Book Growth Rate | -31.3 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 20.06 | |||||
9-Day RSI | 31.15 | |||||
14-Day RSI | 35.68 | |||||
6-1 Month Momentum % | -41.73 | |||||
12-1 Month Momentum % | -53.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.31 | |||||
Quick Ratio | 2.31 | |||||
Cash Ratio | 2.17 | |||||
Days Sales Outstanding | 3515.14 | |||||
Days Payable | 205.56 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.3 | |||||
Shareholder Yield % | -9.41 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -433.9 | |||||
Operating Margin % | -1013440.68 | |||||
Net Margin % | -1028827.12 | |||||
FCF Margin % | -1022170.34 | |||||
ROE % | -94.06 | |||||
ROA % | -79.28 | |||||
ROIC % | -504.49 | |||||
ROC (Joel Greenblatt) % | -2259.01 | |||||
ROCE % | -89.92 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 64000 | |||||
PB Ratio | 5.38 | |||||
Price-to-Tangible-Book | 5.37 | |||||
EV-to-EBIT | -2.86 | |||||
EV-to-EBITDA | -2.86 | |||||
EV-to-Revenue | 29255.08 | |||||
EV-to-FCF | -2.97 | |||||
Price-to-Net-Current-Asset-Value | 5.73 | |||||
Price-to-Net-Cash | 6.47 | |||||
Earnings Yield (Greenblatt) % | -35.08 | |||||
FCF Yield % | -28.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BrightPath Biotherapeutics Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 0.118 | ||
EPS (TTM) (円) | -19.278 | ||
Beta | 0.82 | ||
Volatility % | 24.91 | ||
14-Day RSI | 35.68 | ||
14-Day ATR (円) | 3.937465 | ||
20-Day SMA (円) | 71.8 | ||
12-1 Month Momentum % | -53.18 | ||
52-Week Range (円) | 63 - 185 | ||
Shares Outstanding (Mil) | 66.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BrightPath Biotherapeutics Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BrightPath Biotherapeutics Co Ltd Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
BrightPath Biotherapeutics Co Ltd Frequently Asked Questions
What is BrightPath Biotherapeutics Co Ltd(TSE:4594)'s stock price today?
When is next earnings date of BrightPath Biotherapeutics Co Ltd(TSE:4594)?
Does BrightPath Biotherapeutics Co Ltd(TSE:4594) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |